{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:50:50Z","timestamp":1789487450973,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.7759\/cureus.116285","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:27:26Z","timestamp":1789482446000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Delays in the Care Pathway of Patients With Lung Cancer Treated at a Public Hospital in Costa Rica, 2015-2020"],"prefix":"10.7759","author":[{"given":"Rebeca","family":"Alvarado-Prado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Ortiz-Barboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Blanco-Sabor\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C\u00e9sar","family":"Arguello-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Zavaleta-Monestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102864","article-title":"Health inequalities in cancer care: a literature review of pathways to diagnosis in the United Kingdom","volume":"76","author":"Scott EC","year":"2024","unstructured":"Scott EC, Hoskin PJ. Health inequalities in cancer care: a literature review of pathways to diagnosis in the United Kingdom. EClinicalMedicine. 2024, 76:102864. 10.1016\/j.eclinm.2024.102864","journal-title":"EClinicalMedicine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00258","article-title":"Access to and timeliness of lung cancer surgery, radiation therapy, and systemic therapy in New Zealand: a universal health care context","volume":"10","author":"Gurney J","year":"2024","unstructured":"Gurney J, Davies A, Stanley J, et al.. Access to and timeliness of lung cancer surgery, radiation therapy, and systemic therapy in New Zealand: a universal health care context. JCO Glob Oncol. 2024, 10:e2300258. 10.1200\/GO.23.00258","journal-title":"JCO Glob Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052049","article-title":"Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature)","volume":"26","author":"Smolarz B","year":"2025","unstructured":"Smolarz B, \u0141ukasiewicz H, Samulak D, Piekarska E, Ko\u0142aci\u0144ski R, Romanowicz H. Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature). Int J Mol Sci. 2025, 26:2049. 10.3390\/ijms26052049","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2020.02.11","article-title":"Lung cancer occurrence attributable to passive smoking among never smokers in China: a systematic review and meta-analysis","volume":"9","author":"Du Y","year":"2020","unstructured":"Du Y, Cui X, Sidorenkov G, et al.. Lung cancer occurrence attributable to passive smoking among never smokers in China: a systematic review and meta-analysis. Transl Lung Cancer Res. 2020, 9:204-17. 10.21037\/tlcr.2020.02.11","journal-title":"Transl Lung Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-2025-131","article-title":"Risk factors behind the global lung cancer burden: a pan-database exploration","volume":"14","author":"Cao W","year":"2025","unstructured":"Cao W, You Z, Wang Z, et al.. Risk factors behind the global lung cancer burden: a pan-database exploration. Transl Lung Cancer Res. 2025, 14:2452-69. 10.21037\/tlcr-2025-131","journal-title":"Transl Lung Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-979","article-title":"Recent advancements in lung cancer research: a narrative review","volume":"14","author":"Tang FH","year":"2025","unstructured":"Tang FH, Wong HY, Tsang PS, et al.. Recent advancements in lung cancer research: a narrative review. Transl Lung Cancer Res. 2025, 14:975-90. 10.21037\/tlcr-24-979","journal-title":"Transl Lung Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai AA","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021, 398:535-54. 10.1016\/S0140-6736(21)00312-3","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107867","article-title":"Analyzing diagnostic and treatment wait times for lung cancer patients: key insights from a provincial registry study","volume":"194","author":"Blanco-Villar ML","year":"2024","unstructured":"Blanco-Villar ML, Exp\u00f3sito-Hern\u00e1ndez J, Navarro-Moreno E, L\u00f3pez Mart\u00edn JM, Mota AA, Cou\u00f1ago F. Analyzing diagnostic and treatment wait times for lung cancer patients: key insights from a provincial registry study. Lung Cancer. 2024, 194:107867. 10.1016\/j.lungcan.2024.107867","journal-title":"Lung Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-218059","article-title":"Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study","volume":"78","author":"Klarenbeek SE","year":"2023","unstructured":"Klarenbeek SE, Aarts MJ, van den Heuvel MM, Prokop M, Tummers M, Schuurbiers OC. Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study. Thorax. 2023, 78:467-75. 10.1136\/thoraxjnl-2021-218059","journal-title":"Thorax"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1188\/25.CJON.E28-E36","article-title":"Time to treatment in advanced lung cancer: a quality improvement project using nurse navigation and liquid biopsy","volume":"29","author":"Polo J","year":"2025","unstructured":"Polo J, Coughlin R, Lynch MP. Time to treatment in advanced lung cancer: a quality improvement project using nurse navigation and liquid biopsy. Clin J Oncol Nurs. 2025, 29:E28-36. 10.1188\/25.CJON.E28-E36","journal-title":"Clin J Oncol Nurs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056895","article-title":"Defining timeliness in care for patients with lung cancer: a scoping review","volume":"12","author":"Ansar A","year":"2022","unstructured":"Ansar A, Lewis V, McDonald CF, Liu C, Rahman MA. Defining timeliness in care for patients with lung cancer: a scoping review. BMJ Open. 2022, 12:e056895. 10.1136\/bmjopen-2021-056895","journal-title":"BMJ Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.01.015","article-title":"Time to diagnosis and treatment of lung cancer: a systematic overview of risk factors, interventions and impact on patient outcomes","volume":"166","author":"Zhang J","year":"2022","unstructured":"Zhang J, IJzerman MJ, Oberoi J, et al.. Time to diagnosis and treatment of lung cancer: a systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer. 2022, 166:27-39. 10.1016\/j.lungcan.2022.01.015","journal-title":"Lung Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2009.n.046","article-title":"Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer","volume":"10","author":"Lennes IT","year":"2009","unstructured":"Lennes IT, Lynch TJ. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer. Clin Lung Cancer. 2009, 10:341-6. 10.3816\/CLC.2009.n.046","journal-title":"Clin Lung Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.109330","article-title":"Timeliness of care in patients with lung cancer: a systematic review","volume":"64","author":"Olsson JK","year":"2009","unstructured":"Olsson JK, Schultz EM, Gould MK. Timeliness of care in patients with lung cancer: a systematic review. Thorax. 2009, 64:749-56. 10.1136\/thx.2008.109330","journal-title":"Thorax"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3%3C701::AID-CNCR29%3E3.0.CO;2-V","article-title":"Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool","volume":"88","author":"Malin JL","year":"2000","unstructured":"Malin JL, Asch SM, Kerr EA, McGlynn EA. Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool. Cancer. 2000, 88:3-701. 10.1002\/(SICI)1097-0142(20000201)88:3%3C701::AID-CNCR29%3E3.0.CO;2-V","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602587","article-title":"Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: cancer","volume":"92","author":"Allgar VL","year":"2005","unstructured":"Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: cancer. Br J Cancer. 2005, 92:1959-70. 10.1038\/sj.bjc.6602587","journal-title":"Br J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002674","article-title":"Implementing sustainable primary healthcare reforms: strategies from Costa Rica","volume":"5","author":"Spigel L","year":"2020","unstructured":"Spigel L, Pesec M, Villegas Del Carpio O, et al.. Implementing sustainable primary healthcare reforms: strategies from Costa Rica. BMJ Glob Health. 2020, 5:10.1136\/bmjgh-2020-002674","journal-title":"BMJ Glob Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.19136\/hs.a22n2.5207","article-title":"Comportamiento epidemiol\u00f3gico del c\u00e1ncer de pulm\u00f3n en Costa Rica: incidencia y mortalidad","volume":"22","author":"Alvarado-Prado R","year":"2023","unstructured":"Alvarado-Prado R, Adolfo Ortiz-Barboza D, Alvarado-Prado Direcci\u00f3n R. Comportamiento epidemiol\u00f3gico del c\u00e1ncer de pulm\u00f3n en Costa Rica: incidencia y mortalidad. Horizonte Sanitario. 2023, 22:279-87. 10.19136\/hs.a22n2.5207","journal-title":"Horizonte Sanitario"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4415","article-title":"The burden of lung cancer in women compared with men in the US","volume":"9","author":"Jemal A","year":"2023","unstructured":"Jemal A, Schafer EJ, Sung H, Bandi P, Kratzer T, Islami F, Siegel RL. The burden of lung cancer in women compared with men in the US. JAMA Oncol. 2023, 9:1727-8. 10.1001\/jamaoncol.2023.4415","journal-title":"JAMA Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2217\/lmt-2020-0013","article-title":"Understanding sex disparities in lung cancer incidence: are women more at risk?","volume":"9","author":"Ragavan MV","year":"2020","unstructured":"Ragavan MV, Patel MI. Understanding sex disparities in lung cancer incidence: are women more at risk?. Lung Cancer Manag. 2020, 9:LMT34. 10.2217\/lmt-2020-0013","journal-title":"Lung Cancer Manag"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0100-2021","article-title":"The evolving landscape of sex-based differences in lung cancer: a distinct disease in women","volume":"31","author":"Ragavan M","year":"2022","unstructured":"Ragavan M, Patel MI. The evolving landscape of sex-based differences in lung cancer: a distinct disease in women. Eur Respir Rev. 2022, 31:210100. 10.1183\/16000617.0100-2021","journal-title":"Eur Respir Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15179-5","article-title":"A comparative study on prognostic differences between men and women with non-small cell lung cancer across different antitumor treatment modalities","volume":"25","author":"Li F","year":"2025","unstructured":"Li F, Li F, Lu H, Zhao D. A comparative study on prognostic differences between men and women with non-small cell lung cancer across different antitumor treatment modalities. BMC Cancer. 2025, 25:1802. 10.1186\/s12885-025-15179-5","journal-title":"BMC Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123111","article-title":"Sex differences in lung cancer","volume":"15","author":"May L","year":"2023","unstructured":"May L, Shows K, Nana-Sinkam P, Li H, Landry JW. Sex differences in lung cancer. Cancers (Basel). 2023, 15:3111. 10.3390\/cancers15123111","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071067","article-title":"From diagnosis to survivorship: the role of social determinants in cancer care","volume":"17","author":"Abdullah A","year":"2025","unstructured":"Abdullah A, Liu Z, Molinari M. From diagnosis to survivorship: the role of social determinants in cancer care. Cancers (Basel). 2025, 17:1067. 10.3390\/cancers17071067","journal-title":"Cancers (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-21-428","article-title":"Tumor size as a predictor for prognosis of patients with surgical IIIA-N2 non-small cell lung cancer after surgery","volume":"13","author":"Zhang K","year":"2021","unstructured":"Zhang K, Cai J, Lu C, et al.. Tumor size as a predictor for prognosis of patients with surgical IIIA-N2 non-small cell lung cancer after surgery. J Thorac Dis. 2021, 13:4114-24. 10.21037\/jtd-21-428","journal-title":"J Thorac Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1912-205","article-title":"Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer","volume":"50","author":"\u00d6nal \u00d6","year":"2020","unstructured":"\u00d6nal \u00d6, Ko\u00e7er M, Ero\u011flu HN, Yilmaz SD, Ero\u011flu I, Karado\u011fan D. Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer. Turk J Med Sci. 2020, 50:1838-50. 10.3906\/sag-1912-205","journal-title":"Turk J Med Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207686","article-title":"Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice","volume":"13","author":"Okoli GN","year":"2018","unstructured":"Okoli GN, Kostopoulou O, Delaney BC. Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice. PLoS One. 2018, 13:e0207686. 10.1371\/journal.pone.0207686","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-001021","article-title":"Lung cancer symptoms at diagnosis: results of a nationwide registry study","volume":"5","author":"Ruano-Ravi\u00f1a A","year":"2020","unstructured":"Ruano-Ravi\u00f1a A, Provencio M, Calvo de Juan V, et al.. Lung cancer symptoms at diagnosis: results of a nationwide registry study. ESMO Open. 2020, 5:e001021. 10.1136\/esmoopen-2020-001021","journal-title":"ESMO Open"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2022.08.036","article-title":"Early diagnosis and lung cancer screening","volume":"34","author":"Balata H","year":"2022","unstructured":"Balata H, Quaife SL, Craig C, et al.. Early diagnosis and lung cancer screening. Clin Oncol (R Coll Radiol). 2022, 34:708-15. 10.1016\/j.clon.2022.08.036","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5005","article-title":"Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: a qualitative interview study","volume":"28","author":"Cunningham Y","year":"2019","unstructured":"Cunningham Y, Wyke S, Blyth KG, et al.. Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: a qualitative interview study. Psychooncology. 2019, 28:718-25. 10.1002\/pon.5005","journal-title":"Psychooncology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104323","article-title":"Impact of smoking cessation duration on lung cancer mortality: A systematic review and meta-analysis","volume":"196","author":"Lai H","year":"2024","unstructured":"Lai H, Liu Q, Ye Q, et al.. Impact of smoking cessation duration on lung cancer mortality: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2024, 196:104323. 10.1016\/j.critrevonc.2024.104323","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24813","article-title":"Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB\/IV nonsmall cell lung cancer","volume":"116","author":"Janjigian YY","year":"2010","unstructured":"Janjigian YY, McDonnell K, Kris MG, et al.. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB\/IV nonsmall cell lung cancer. Cancer. 2010, 116:670-5. 10.1002\/cncr.24813","journal-title":"Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.12.005","article-title":"Quitting smoking at or around diagnosis improves the overall survival of lung cancer patients: a systematic review and meta-analysis","volume":"17","author":"Caini S","year":"2022","unstructured":"Caini S, Del Riccio M, Vettori V, et al.. Quitting smoking at or around diagnosis improves the overall survival of lung cancer patients: a systematic review and meta-analysis. J Thorac Oncol. 2022, 17:623-36. 10.1016\/j.jtho.2021.12.005","journal-title":"J Thorac Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202410-1029RL","article-title":"Use of biomarker testing in advanced non-small cell lung cancer: a retrospective analysis","volume":"22","author":"Duong B","year":"2025","unstructured":"Duong B, Al-Ani A, Vu L, et al.. Use of biomarker testing in advanced non-small cell lung cancer: a retrospective analysis. Ann Am Thorac Soc. 2025, 22:1088-91. 10.1513\/AnnalsATS.202410-1029RL","journal-title":"Ann Am Thorac Soc"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2025.100816","article-title":"Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data","volume":"7","author":"Behera M","year":"2026","unstructured":"Behera M, Joseph G, Rupji M, et al.. Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data. JTO Clin Res Rep. 2026, 7:100816. 10.1016\/j.jtocrr.2025.100816","journal-title":"JTO Clin Res Rep"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251338046","article-title":"Efficacy and safety of distinct regimens for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review and network meta-analysis","volume":"17","author":"Zhang W","year":"2025","unstructured":"Zhang W, Xiong J, Li Y, et al.. Efficacy and safety of distinct regimens for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review and network meta-analysis. Ther Adv Med Oncol. 2025, 17:","journal-title":"Ther Adv Med Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2217\/lmt-2020-0011","article-title":"Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer\u00a0harboring epidermal growth factor receptor mutation: a network meta-analysis","volume":"10","author":"Alanazi A","year":"2020","unstructured":"Alanazi A, Yunusa I, Elenizi K, Alzarea AI. Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer\u00a0harboring epidermal growth factor receptor mutation: a network meta-analysis. Lung Cancer Manag. 2020, 10:LMT43. 10.2217\/lmt-2020-0011","journal-title":"Lung Cancer Manag"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/0218492319881036","article-title":"Timeliness of lung cancer diagnosis and treatment: a single-center experience","volume":"27","author":"Rao SS","year":"2019","unstructured":"Rao SS, Saha S. Timeliness of lung cancer diagnosis and treatment: a single-center experience. Asian Cardiovasc Thorac Ann. 2019, 27:670-6. 10.1177\/0218492319881036","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70026","article-title":"Evaluating the time interval between symptoms onset, diagnosis, and therapeutic intervention in lung cancer: a cross-sectional study in southern Iran","volume":"7","author":"Salehi A","year":"2024","unstructured":"Salehi A, Rezvani A, Fallahi MJ, Gholamabbas G, Moayedfar M. Evaluating the time interval between symptoms onset, diagnosis, and therapeutic intervention in lung cancer: a cross-sectional study in southern Iran. Cancer Rep (Hoboken). 2024, 7:e70026. 10.1002\/cnr2.70026","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2025.1825","article-title":"Duration of intervals in the care-seeking pathway of lung cancer in Nepal","volume":"19","author":"Pandey S","year":"2025","unstructured":"Pandey S, Paudel BD, Acharya B, et al.. Duration of intervals in the care-seeking pathway of lung cancer in Nepal. Ecancermedicalscience. 2025, 19:1825. 10.3332\/ecancer.2025.1825","journal-title":"Ecancermedicalscience"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3399\/BJGPO.2020.0130","article-title":"Evaluating the delay prior to primary care presentation in patients with lung cancer: a cohort study","volume":"5","author":"Kotecha J","year":"2021","unstructured":"Kotecha J, Clark A, Burton M, et al.. Evaluating the delay prior to primary care presentation in patients with lung cancer: a cohort study. BJGP Open. 2021, 5:10.3399\/BJGPO.2020.0130","journal-title":"BJGP Open"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02796-w","article-title":"Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review","volume":"24","author":"Guirado M","year":"2022","unstructured":"Guirado M, Fern\u00e1ndez Mart\u00edn E, Fern\u00e1ndez Villar A, Navarro Mart\u00edn A, S\u00e1nchez-Hern\u00e1ndez A. Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review. Clin Transl Oncol. 2022, 24:1549-68. 10.1007\/s12094-022-02796-w","journal-title":"Clin Transl Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.08.051","article-title":"Impact of delays in lung cancer treatment on survival","volume":"160","author":"Zuniga PV","year":"2021","unstructured":"Zuniga PV, Ost DE. Impact of delays in lung cancer treatment on survival. Chest. 2021, 160:1934-58. 10.1016\/j.chest.2021.08.051","journal-title":"Chest"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.12.015","article-title":"A systematic review of survival following anti-cancer treatment for small cell lung cancer","volume":"141","author":"Jones GS","year":"2020","unstructured":"Jones GS, Elimian K, Baldwin DR, Hubbard RB, McKeever TM. A systematic review of survival following anti-cancer treatment for small cell lung cancer. Lung Cancer. 2020, 141:44-55. 10.1016\/j.lungcan.2019.12.015","journal-title":"Lung Cancer"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36623-1","article-title":"Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting","volume":"13","author":"Belaroussi Y","year":"2023","unstructured":"Belaroussi Y, Bouteiller F, Bellera C, et al.. Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting. Sci Rep. 2023, 13:9584. 10.1038\/s41598-023-36623-1","journal-title":"Sci Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.15170","article-title":"Observed and relative survival trends of lung cancer: a systematic review of population-based cancer registration data","volume":"15","author":"Bi JH","year":"2024","unstructured":"Bi JH, Tuo JY, Xiao YX, et al.. Observed and relative survival trends of lung cancer: a systematic review of population-based cancer registration data. Thorac Cancer. 2024, 15:142-51. 10.1111\/1759-7714.15170","journal-title":"Thorac Cancer"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12267-w","article-title":"Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis","volume":"24","author":"Okayama T","year":"2024","unstructured":"Okayama T, Suzuki K, Morishita S, Inoue J, Tanaka T, Nakano J, Fukushima T. Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis. BMC Cancer. 2024, 24:495. 10.1186\/s12885-024-12267-w","journal-title":"BMC Cancer"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2021.103829","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra KC","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn). 2021, 25:45-52. 10.5114\/wo.2021.103829","journal-title":"Contemp Oncol (Pozn)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523046-clinical-characteristics-and-delays-in-the-care-pathway-of-patients-with-lung-cancer-treated-at-a-public-hospital-in-costa-rica-2015-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:27:27Z","timestamp":1789482447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523046-clinical-characteristics-and-delays-in-the-care-pathway-of-patients-with-lung-cancer-treated-at-a-public-hospital-in-costa-rica-2015-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.116285","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}